Skip to main content

Articles

Page 30 of 69

  1. The quality of systematic reviews and meta-analyses (SR/MAs) depends on the extent of the methods used. We investigated the methodological steps used by authors of SR/MAs of clinical trials via an author survey.

    Authors: Hoang Thi Nam Giang, Ali Mahmoud Ahmed, Reem Yousry Fala, Mohamed Magdy Khattab, Mona Hassan Ahmed Othman, Sara Attia Mahmoud Abdelrahman, Le Phuong Thao, Ahmed Elsaid Abd Elsamie Gabl, Samar Ahmed Elrashedy, Peter N. Lee, Kenji Hirayama, Hosni Salem and Nguyen Tien Huy
    Citation: BMC Medical Research Methodology 2019 19:164
  2. Many prodromal Alzheimer’s disease trials collect two types of data: the time until clinical diagnosis of dementia and longitudinal patient information. These data are often analysed separately, although they ...

    Authors: Floor M. van Oudenhoven, Sophie H.N. Swinkels, Tobias Hartmann, Hilkka Soininen, Anneke M.J. van Hees and Dimitris Rizopoulos
    Citation: BMC Medical Research Methodology 2019 19:163
  3. Omics data can be very informative in survival analysis and may improve the prognostic ability of classical models based on clinical risk factors for various diseases, for example breast cancer. Recent researc...

    Authors: Alexander Volkmann, Riccardo De Bin, Willi Sauerbrei and Anne-Laure Boulesteix
    Citation: BMC Medical Research Methodology 2019 19:162
  4. In many clinical trials continuous outcomes are dichotomized to compare proportions of patients who respond. A common and recommended approach to handling missing data in responder analysis is to impute as non...

    Authors: Lysbeth Floden and Melanie L. Bell
    Citation: BMC Medical Research Methodology 2019 19:161
  5. Statistics are frequently used in health advocacy to attract attention, but are often misinterpreted. The Figure Interpretation Assessment Tool–Health (FIAT-Health) 1.0 was developed to support systematic asse...

    Authors: Reinie G. Gerrits, Niek S. Klazinga, Michael J. van den Berg and Dionne S. Kringos
    Citation: BMC Medical Research Methodology 2019 19:160
  6. In the original publication of this article [1], “=1 −  = 1 −   ≈ s” was mistakenly added after the sentence “ In this method, the unadjusted p-values pj are multiplied by the number of primary outcome” in the Me...

    Authors: Victoria Vickerstaff, Rumana Z. Omar and Gareth Ambler
    Citation: BMC Medical Research Methodology 2019 19:158

    The original article was published in BMC Medical Research Methodology 2019 19:129

  7. Sleeping under a long-lasting insecticidal net (LLIN) is recommended for all pregnant women in sub-Saharan Africa, due to the high prevalence of malaria infection and its associated complications in the region...

    Authors: Ahmed Dahiru Balami, Salmiah Md Said, Nor Afiah Mohd Zulkefli, Norsa’adah Bachok and Emmanuel Luke Balami
    Citation: BMC Medical Research Methodology 2019 19:157
  8. Pragmatic randomized, controlled trials (PCTs) test the effectiveness of interventions implemented in routine clinical practice. Because PCT findings are generalizable, this approach is gaining momentum among ...

    Authors: Rosa R. Baier, Eric Jutkowitz, Susan L. Mitchell, Ellen McCreedy and Vincent Mor
    Citation: BMC Medical Research Methodology 2019 19:156
  9. The identification of sections in narrative content of Electronic Health Records (EHR) has demonstrated to improve the performance of clinical extraction tasks; however, there is not yet a shared understanding...

    Authors: Alexandra Pomares-Quimbaya, Markus Kreuzthaler and Stefan Schulz
    Citation: BMC Medical Research Methodology 2019 19:155
  10. In low-income countries, studies demonstrate greater access and utilization of maternal and neonatal health services, yet mortality rates remain high with poor quality increasingly scrutinized as a potential p...

    Authors: Danielle Wilhelm, Julia Lohmann, Manuela De Allegri, Jobiba Chinkhumba, Adamson S. Muula and Stephan Brenner
    Citation: BMC Medical Research Methodology 2019 19:154
  11. The purpose of this paper is to systematically review the literature on the relationship between socioeconomic status (SES) and influenza immunization and to examine how certain measures of SES may influence i...

    Authors: Kelsey Lucyk, Kimberley A. Simmonds, Diane L. Lorenzetti, Steven J. Drews, Lawrence W. Svenson and Margaret L. Russell
    Citation: BMC Medical Research Methodology 2019 19:153
  12. In recent years, the availability of publicly available data related to public health has significantly increased. These data have substantial potential to develop public health policy; however, this requires ...

    Authors: Paul van Schaik, Yonghong Peng, Adedokun Ojelabi and Jonathan Ling
    Citation: BMC Medical Research Methodology 2019 19:152
  13. Improving response rates in epidemiologic studies is important for the generalizability of the outcome. The aim of this study was to examine whether it can be advantageous for participation to target different...

    Authors: Anne Illemann Christensen, Peter Lynn and Janne Schurmann Tolstrup
    Citation: BMC Medical Research Methodology 2019 19:151
  14. Randomized controlled trials are the gold-standard for clinical trials. However, randomization is not always feasible. In this article we propose a prospective and adaptive matched case-control trial design as...

    Authors: Dorothea Weber, Lorenz Uhlmann, Silvia Schönenberger and Meinhard Kieser
    Citation: BMC Medical Research Methodology 2019 19:150
  15. In the context of environmentally influenced communicable diseases, proximity to environmental sources results in spatial heterogeneity of risk, which is sometimes difficult to measure in the field. Most preve...

    Authors: Abdoulaye Guindo, Issaka Sagara, Boukary Ouedraogo, Kankoe Sallah, Mahamadoun Hamady Assadou, Sara Healy, Patrick Duffy, Ogobara K. Doumbo, Alassane Dicko, Roch Giorgi and Jean Gaudart
    Citation: BMC Medical Research Methodology 2019 19:149
  16. There is an increasing number of published systematic reviews (SR) of dose-response meta-analyses (DRMAs) over the past decades. However, the quality of abstract reporting of these SR-DRMAs remains to be under...

    Authors: Peng-Li Jia, Bin Xu, Jing-Min Cheng, Xi-Hao Huang, Joey S. W. Kwong, Yu Liu, Chao Zhang, Ying Han and Chang Xu
    Citation: BMC Medical Research Methodology 2019 19:148
  17. The attendance to cervical cancer screening is low among immigrants in many high-income countries. Although several interventions have been experimentally tested,implementation remains a challenge. Several fac...

    Authors: Samera A. Qureshi, Abdi Gele, Prabhjot Kour, Kathy A. Møen, Bernadette Kumar and Esperanza Diaz
    Citation: BMC Medical Research Methodology 2019 19:147
  18. To reliably evaluate the acceptance and use of computer-based prostate cancer decision aids (CBDAs) for African-American men, culturally relevant measures are needed. This study describes the development and i...

    Authors: Otis L. Owens, Nikki R. Wooten and Abbas S. Tavakoli
    Citation: BMC Medical Research Methodology 2019 19:146
  19. The life expectancy of cancer patients, and the loss in expectation of life as compared to the life expectancy without cancer, is a useful measure of cancer patient survival and complement the more commonly re...

    Authors: Therese M.-L. Andersson, Mark J. Rutherford and Paul C. Lambert
    Citation: BMC Medical Research Methodology 2019 19:145
  20. Postal surveys are widely used in scientific studies, including dietary surveys, but few studies about methods to increase participation in national dietary surveys are published. In the present study we compa...

    Authors: Jannicke Borch Myhre, Lene Frost Andersen, Kristin Holvik, Helene Astrup and Anne Lene Kristiansen
    Citation: BMC Medical Research Methodology 2019 19:144
  21. Sequence symmetry analysis (SSA) is a signal detection method that can be used to assist with adverse drug event detection. It provides both a risk estimate and a data visualisation. Published methods provide ...

    Authors: Adrian Kym Preiss, Elizabeth Ellen Roughead and Nicole Leanne Pratt
    Citation: BMC Medical Research Methodology 2019 19:143
  22. Incidence rates of advanced cancer stages are important, e.g., for monitoring cancer screening programs. However, information from cancer registries on tumor stage is often incomplete. Exemplified by colorecta...

    Authors: Katja Anita Oppelt, Sabine Luttmann, Klaus Kraywinkel and Ulrike Haug
    Citation: BMC Medical Research Methodology 2019 19:142
  23. In most cases, the total scores from different instruments assessing the same construct are not directly comparable, but must be equated. In this study we aimed to illustrate a novel test equating methodology ...

    Authors: Núria Duran Adroher, Svend Kreiner, Carolyn Young, Roger Mills and Alan Tennant
    Citation: BMC Medical Research Methodology 2019 19:141
  24. The multicriteria decision method (MCDM) aims to find conflicts among alternatives by comparing and evaluating them according to various criteria to reach the best compromise solution. The evaluation of a new ...

    Authors: Giovanni Improta, Antonietta Perrone, Mario Alessandro Russo and Maria Triassi
    Citation: BMC Medical Research Methodology 2019 19:140
  25. Information exchange between physician and patient is crucial to achieve patient involvement, shared decision making and treatment adherence. No reliable method exists for measuring how much information physic...

    Authors: J. M. Nordfalk, P. Gulbrandsen, J. Gerwing, M. Nylenna and J. Menichetti
    Citation: BMC Medical Research Methodology 2019 19:139
  26. Monetary incentive is often used to increase response rate in smokers’ survey, but such effect of prepaid and promised incentives in a follow-up survey is unknown. We compared the effect of different incentive...

    Authors: Yee Tak Derek Cheung, Xue Weng, Man Ping Wang, Sai Yin Ho, Antonio Cho Shing Kwong, Vienna Wai Yin Lai and Tai Hing Lam
    Citation: BMC Medical Research Methodology 2019 19:138
  27. Randomised controlled trials (RCTs) are considered the gold standard when evaluating the causal effects of healthcare interventions. When RCTs cannot be used (e.g. ethically difficult), the interrupted time se...

    Authors: Jemma Hudson, Shona Fielding and Craig R. Ramsay
    Citation: BMC Medical Research Methodology 2019 19:137
  28. In theory, efficient design of randomized controlled trials (RCTs) involves randomization algorithms that control baseline variable imbalance efficiently, and corresponding analysis involves pre-specified adju...

    Authors: Jody D. Ciolino, Hannah L. Palac, Amy Yang, Mireya Vaca and Hayley M. Belli
    Citation: BMC Medical Research Methodology 2019 19:136
  29. Participation in epidemiologic studies is steadily declining, which may result in selection bias. It is therefore an ongoing challenge to clarify the determinants of participation to judge possible selection e...

    Authors: Cornelia Enzenbach, Barbara Wicklein, Kerstin Wirkner and Markus Loeffler
    Citation: BMC Medical Research Methodology 2019 19:135
  30. Clinical guidelines produced in developed nations may not be appropriate in resource-constrained environments, due to differences in cultural, societal, economic and policy contexts. The purpose of this articl...

    Authors: D. V. Ernstzen, S. L. Hillier and Q. A. Louw
    Citation: BMC Medical Research Methodology 2019 19:134
  31. Stringent requirements exist regarding the transparency of the study selection process and the reliability of results. A 2-step selection process is generally recommended; this is conducted by 2 reviewers inde...

    Authors: Siw Waffenschmidt, Marco Knelangen, Wiebke Sieben, Stefanie Bühn and Dawid Pieper
    Citation: BMC Medical Research Methodology 2019 19:132
  32. Report cards on the health care system increasingly report provider-specific performance on indicators that measure the quality of health care delivered. A natural reaction to the publishing of hospital-specif...

    Authors: Peter C. Austin, Iris E. Ceyisakar, Ewout W. Steyerberg, Hester F. Lingsma and Perla J. Marang-van de Mheen
    Citation: BMC Medical Research Methodology 2019 19:131
  33. Tacrolimus (TAC) is an immunosuppressant drug given to kidney transplant recipients post-transplant to prevent antibody formation and kidney rejection. The optimal therapeutic dose for TAC is poorly defined an...

    Authors: Kristen R. Campbell, Elizabeth Juarez-Colunga, Gary K. Grunwald, James Cooper, Scott Davis and Jane Gralla
    Citation: BMC Medical Research Methodology 2019 19:130
  34. Multiple primary outcomes may be specified in randomised controlled trials (RCTs). When analysing multiple outcomes it’s important to control the family wise error rate (FWER). A popular approach to do this is...

    Authors: Victoria Vickerstaff, Rumana Z. Omar and Gareth Ambler
    Citation: BMC Medical Research Methodology 2019 19:129

    The Correction to this article has been published in BMC Medical Research Methodology 2019 19:158

  35. A large number of articles examined the preventability rate of readmissions, but comparison and interpretability of these preventability rates is complicated due to the large heterogeneity of methods that were...

    Authors: Eva-Linda Kneepkens, Corline Brouwers, Richelle Glory Singotani, Martine C. de Bruijne and Fatma Karapinar-Çarkit
    Citation: BMC Medical Research Methodology 2019 19:128
  36. The number of web-based E-epidemiologic studies using online recruitment methods is increasing. However, the optimal online recruitment method in terms of maximizing recruitment rates is still unknown. Our aim...

    Authors: Cauane Blumenberg, Ana Maria Baptista Menezes, Helen Gonçalves, Maria Cecília Formoso Assunção, Fernando César Wehrmeister and Aluísio J. D. Barros
    Citation: BMC Medical Research Methodology 2019 19:127
  37. The study design and protocol that underpin a randomised controlled trial (RCT) are critical for the ultimate success of the trial. Although RCTs are considered the gold standard for research, there are multip...

    Authors: Charlotte L. Hall, Susan Brown, Marilyn James, Jennifer L. Martin, Nikki Brown, Kim Selby, Julie Clarke, Laura Williams, Kapil Sayal, Chris Hollis and Madeleine J. Groom
    Citation: BMC Medical Research Methodology 2019 19:126
  38. Use of big data is becoming increasingly popular in medical research. Since big data-based projects differ notably from classical research studies, both in terms of scope and quality, a debate is apt as to whe...

    Authors: Amke Caliebe, Friedhelm Leverkus, Gerd Antes and Michael Krawczak
    Citation: BMC Medical Research Methodology 2019 19:125
  39. Two randomized controlled trials (RCTs) were conducted to explore the utility of the Mechanical Turk (MTurk) crowdsourcing platform to conduct rapid trials evaluating online interventions for unhealthy alcohol...

    Authors: John A. Cunningham, Alexandra Godinho and Nicolas Bertholet
    Citation: BMC Medical Research Methodology 2019 19:124
  40. Cluster randomised trials with unequal sized clusters often have lower precision than with clusters of equal size. To allow for this, sample sizes are inflated by a modified version of the design effect for cl...

    Authors: James Thomas Martin, Karla Hemming and Alan Girling
    Citation: BMC Medical Research Methodology 2019 19:123
  41. Accurate measurement of health literacy is essential to improve accessibility and effectiveness of health care and prevention. One measure frequently applied in international research is the Short Assessment o...

    Authors: A. J. Woudstra, C. S. Meppelink, H. Pander Maat, J. Oosterhaven, M. P. Fransen and A. L. Dima
    Citation: BMC Medical Research Methodology 2019 19:122
  42. Small group research in healthcare is important because it deals with interaction and decision-making processes that can help to identify and improve safer patient treatment and care. However, the number of st...

    Authors: Lisa Aufegger, Colin Bicknell, Emma Soane, Hutan Ashrafian and Ara Darzi
    Citation: BMC Medical Research Methodology 2019 19:121
  43. Health researchers often use survey studies to examine associations between risk factors at one time point and health outcomes later in life. Previous studies have shown that missing not at random (MNAR) may p...

    Authors: Kristin Gustavson, Espen Røysamb and Ingrid Borren
    Citation: BMC Medical Research Methodology 2019 19:120
  44. The Fred Hutchinson Cancer Research Center has engaged an External Stakeholder Advisory Group (ESAG) in the planning and implementation of the TrACER Study (S1415CD), a five-year pragmatic clinical trial asses...

    Authors: Sarah Barger, Sean D. Sullivan, Ari Bell-Brown, Brad Bott, Anne Marie Ciccarella, John Golenski, Mark Gorman, Judy Johnson, Karma Kreizenbeck, Florence Kurttila, Ginny Mason, Jamie Myers, Carole Seigel, James L. Wade III, Guneet Walia, Kate Watabayashi…
    Citation: BMC Medical Research Methodology 2019 19:119
  45. Clinical prediction models are not routinely validated. To facilitate validation procedures, the online Evidencio platform (https://​www.​evidencio.​com) ...

    Authors: Cornelia D. van Steenbeek, Marissa C. van Maaren, Sabine Siesling, Annemieke Witteveen, Xander A. A. M. Verbeek and Hendrik Koffijberg
    Citation: BMC Medical Research Methodology 2019 19:117
  46. We determined whether it is feasible to identify important changes in care management resulting from cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervent...

    Authors: Maria Pufulete, Jessica Harris, Stephen Dorman, Lynn Cook, Chiara Bucciarelli-Ducci, John P. Greenwood, Richard Anderson, Rachel Brierley and Barnaby C. Reeves
    Citation: BMC Medical Research Methodology 2019 19:116

    The Correction to this article has been published in BMC Medical Research Methodology 2019 19:190

  47. Comorbidity measures, such as the Charlson Comorbidity Index (CCI) and Elixhauser Method (EM), are frequently used for risk-adjustment by healthcare researchers. This study sought to create CCI and EM lists of...

    Authors: David Metcalfe, James Masters, Antonella Delmestri, Andrew Judge, Daniel Perry, Cheryl Zogg, Belinda Gabbe and Matthew Costa
    Citation: BMC Medical Research Methodology 2019 19:115

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    7.0 - 5-year Impact Factor
    2.055 - SNIP (Source Normalized Impact per Paper)
    1.778 - SJR (SCImago Journal Rank)

    2023 Speed
    40 days submission to first editorial decision for all manuscripts (Median)
    210 days submission to accept (Median)

    2023 Usage 
    4,638,094 downloads
    3,126 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal